Skip to content

Author

Ya-Ning Zhang

We have 1 of 3 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Conference Open access 2025

The Role of Epigenetic Drugs in Cancer Immunotherapy

Clinical evidence increasingly supports the synergistic potential of combining epigenetic drugs with established immunotherapy, especially immune checkpoint inhibitors, especially immune checkpoint inhibitors.

Ya-Ning Zhang · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.